Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Ardy Arianpour, Jim Lupski, John Doulis

Premium

Pathway Genomics has appointed Ardy Arianpour as chief strategy officer. He joins Pathway from Ambry Genetics, where he was most recently senior vice president of development. Previously, he was regional manager of business development at Cogenics. He holds a BS in biological sciences from the University of California, Irvine and an MBA in strategic management from Marshall Goldsmith School of Management.


Baylor College of Medicine's Jim Lupski has received the 2014 Environmental Mutagenesis and Genomics Society Award in recognition of his work in characterizing human mutations and linking them to disease. Lupski, a professor of molecular and human genetics at BCM, has relied on chromosomal microarrays and whole-genome sequencing to discover several disease genes, including the first gene for Charcot-Marie Tooth syndrome.

EMGS recognizes one researcher each year for outstanding research contributions in the area of environmental mutagenesis and genomics. Lupski will receive the award on Sept. 16 at the society's annual meeting in Orlando, Fla.


GenomOncology has named John Doulis to serve on its board of directors, in connection with an investment from TriStar Technology Ventures.

Doulis is chief information officer for MedCare Investment Funds, which is a partner fund to TriStar. He has two decades of experience as a physician, executive, scientist, and healthcare information systems designer and manager, including serving as assistant vice chancellor and chief operations officer for the Informatics Center at Vanderbilt University.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.